Summary of main clinical trialsdoi:10.1111/j.1755-3768.2017.01521John Wiley & Sons, LtdActa Ophthalmologica
Infliximab, an anti-TNF treatment, has been successful in clinical trials in reducing TNFα induced production of other inflammatory mediators, thereby reducing the signs and symptoms of RA. Infliximab is a chimeric monoclonal antibody that is 75% human and 25% mouse protein.1 The mouse portion ...
Clinical trials: a summary. Focuses on the increase in the number of clinical trials in the U.S. Means of assessing the efficacy of an intervention in internal medicine; Commonality o... Wilhelmsen,L.,Held,... - 《Journal of Internal Medicine》 被引量: 0发表: 2005年 ACC/AHA/ACP-ASIM...
Over the course of 2023, numerous key clinical trials with valuable contributions to clinical cardiology were published or presented at major international conferences. This review seeks to summarise these trials and reflect on their clinical context. Methods The authors collated and reviewed clinical tri...
Over the course of 2022, numerous key clinical trials with valuable contributions to clinical cardiology were published or presented at major international conferences. This review seeks to summarise these trials and to reflect on their clinical context. Methods The authors reviewed clinical trials presen...
The purpose of the ISE is to describe the available information regarding effectiveness, delineate strengths and weaknesses, and highlight important missing information. Generally, analyses in the ISE are based primarily on the clinical effectiveness data included in the application, but they may also...
Two randomized, double-blind clinical trials in cerebrovascular disease are described. The Controlled trial of Aspirin in Cerebral Ischemia compared aspirin (650 mg twice daily) with placebo in medically and surgically treated groups of patients who had experienced transient ischemic attacks. The Randomiz...
For the latest information, see the following: Clinical trials Public health information Research information Next: Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing by the Infectious Diseases Society of America What to Read Next on Medscape Related Conditions and Diseases CO...
Where trials of people with type 1 diabetes and DKD are lacking, it is reasonable to extrapolate general population data and use CKD stage (Table 1) as a CVD risk equivalent. In CKD stages G3–5, the elevated risk of CVD justifies the initiation of lipid-lowering agents, notwithstanding th...
Strategies and Endpoints of Antifibrotic Drug Trials: Summary and Recommendations From the AASLD Emerging Trends Conference, Chicago, June 2014 There is an urgent need to develop antifibrotic th NJ Torok,D Schuppan,SL Friedman,... - 《Hepatology Official Journal of the American Association for the...